Scribe Therapeutics Stock

scribetx.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $121.16MM

Scribe Therapeutics focuses on creating therapies that permanently treat the underlying cause of disease.

Register for Details

For more details on financing and valuation for Scribe Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Scribe Therapeutics.

Register Today

Other companies like Scribe Therapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B